About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITINGNA

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

Endoscopic Ultrasound-Guided Radiofrequency Ablation of Pancreatic Cysts - A Safety and Efficacy Trial (ERASE Study)

NCT05961982•Ohio State University Comprehensive Cancer Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pancreatic Neoplasm

Interventions

Chemical Ablation

Computed Tomography

+5 more

Locations

1

United States

Locations (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Key Dates

Start Date

April 24, 2023

Primary Completion Date

December 31, 2026

Completion Date

December 31, 2027

Last Updated

March 4, 2025

Related Studies

RECRUITINGPhase 1/2

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Solid Tumor, AdultColorectal Cancer+18 more

RECRUITINGPhase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

MRE for Diagnosis of Pancreatic Masses

NCT06526442

Pancreatic NeoplasmMagnetic Resonance Imaging

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

NCT07396662

Pancreatic Neoplasm

RECRUITINGPhase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

NCT06411795

Duodenal NeoplasmPancreatic Neoplasm

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

NCT07139236

Pancreatic NeoplasmsPancreatic Fistula

View all related studies

Contacts

The Ohio State University Comprehensive Cancer Center

CONTACT

800-293-5066 OSUCCCClinicaltrials@osumc.edu

Sponsors

Lead Sponsor

Ohio State University Comprehensive Cancer Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions